| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Software tools for high-throughput analysis and archiving of immunohistochemistry staining data obtained with tissue microarrays.
|
Am J Pathol
|
2002
|
3.11
|
|
2
|
Nanofluidic proteomic assay for serial analysis of oncoprotein activation in clinical specimens.
|
Nat Med
|
2009
|
2.31
|
|
3
|
Oral and extraoral plasmablastic lymphoma: similarities and differences in clinicopathologic characteristics.
|
Am J Clin Pathol
|
2010
|
2.10
|
|
4
|
The Stanford Tissue Microarray Database.
|
Nucleic Acids Res
|
2007
|
1.96
|
|
5
|
Expression of CD163 (hemoglobin scavenger receptor) in normal tissues, lymphomas, carcinomas, and sarcomas is largely restricted to the monocyte/macrophage lineage.
|
Am J Surg Pathol
|
2005
|
1.74
|
|
6
|
Atypical cellular disorders.
|
Hematology Am Soc Hematol Educ Program
|
2004
|
1.70
|
|
7
|
Rituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2 trial.
|
Blood
|
2003
|
1.66
|
|
8
|
The differential expression of LCK and BAFF-receptor and their role in apoptosis in human lymphomas.
|
Haematologica
|
2006
|
1.60
|
|
9
|
Bevacizumab and cyclosphosphamide, doxorubicin, vincristine and prednisone in combination for patients with peripheral T-cell or natural killer cell neoplasms: an Eastern Cooperative Oncology Group study (E2404).
|
Leuk Lymphoma
|
2013
|
1.51
|
|
10
|
Embryonic stem cell-derived endothelial cells engraft into the ischemic hindlimb and restore perfusion.
|
Arterioscler Thromb Vasc Biol
|
2010
|
1.42
|
|
11
|
Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment.
|
Blood
|
2011
|
1.41
|
|
12
|
PTP1B is a negative regulator of interleukin 4-induced STAT6 signaling.
|
Blood
|
2008
|
1.32
|
|
13
|
Microvessel density and expression of vascular endothelial growth factor and its receptors in diffuse large B-cell lymphoma subtypes.
|
Am J Pathol
|
2007
|
1.30
|
|
14
|
Expression of the B-cell proliferation marker MUM1 by melanocytic lesions and comparison with S100, gp100 (HMB45), and MelanA.
|
Mod Pathol
|
2003
|
1.29
|
|
15
|
Oncogenic regulators and substrates of the anaphase promoting complex/cyclosome are frequently overexpressed in malignant tumors.
|
Am J Pathol
|
2007
|
1.28
|
|
16
|
Cyclin D3 coordinates the cell cycle during differentiation to regulate erythrocyte size and number.
|
Genes Dev
|
2012
|
1.23
|
|
17
|
Improvements in observed and relative survival in follicular grade 1-2 lymphoma during 4 decades: the Stanford University experience.
|
Blood
|
2013
|
1.20
|
|
18
|
Apoptosis stimulating protein of p53 (ASPP2) expression differs in diffuse large B-cell and follicular center lymphoma: correlation with clinical outcome.
|
Leuk Lymphoma
|
2002
|
1.18
|
|
19
|
MicroRNAs are independent predictors of outcome in diffuse large B-cell lymphoma patients treated with R-CHOP.
|
Clin Cancer Res
|
2011
|
1.17
|
|
20
|
Prognostic significance of VEGF, VEGF receptors, and microvessel density in diffuse large B cell lymphoma treated with anthracycline-based chemotherapy.
|
Lab Invest
|
2007
|
1.16
|
|
21
|
Clinicopathologic and molecular features of 122 Brazilian cases of nodal and extranodal NK/T-cell lymphoma, nasal type, with EBV subtyping analysis.
|
Am J Surg Pathol
|
2011
|
1.16
|
|
22
|
Characterization of variant patterns of nodular lymphocyte predominant hodgkin lymphoma with immunohistologic and clinical correlation.
|
Am J Surg Pathol
|
2003
|
1.16
|
|
23
|
The NFATc1 transcription factor is widely expressed in white cells and translocates from the cytoplasm to the nucleus in a subset of human lymphomas.
|
Br J Haematol
|
2005
|
1.12
|
|
24
|
Immunohistochemical characterization of nasal-type extranodal NK/T-cell lymphoma using a tissue microarray: an analysis of 84 cases.
|
Am J Clin Pathol
|
2008
|
1.10
|
|
25
|
Integration of genomic medicine into pathology residency training: the stanford open curriculum.
|
J Mol Diagn
|
2013
|
1.03
|
|
26
|
CD30 targeting with brentuximab vedotin: a novel therapeutic approach to primary effusion lymphoma.
|
Blood
|
2013
|
1.02
|
|
27
|
Mature results of a phase II study of rituximab therapy for nodular lymphocyte-predominant Hodgkin lymphoma.
|
J Clin Oncol
|
2014
|
1.00
|
|
28
|
TdT+ T-lymphoblastic populations are increased in Castleman disease, in Castleman disease in association with follicular dendritic cell tumors, and in angioimmunoblastic T-cell lymphoma.
|
Am J Surg Pathol
|
2012
|
1.00
|
|
29
|
Extracellular signal-regulated kinase positively regulates the oncogenic activity of MCT-1 in diffuse large B-cell lymphoma.
|
Cancer Res
|
2009
|
0.99
|
|
30
|
Germinal centre protein HGAL promotes lymphoid hyperplasia and amyloidosis via BCR-mediated Syk activation.
|
Nat Commun
|
2013
|
0.98
|
|
31
|
Efficacy of bortezomib in a direct xenograft model of primary effusion lymphoma.
|
Proc Natl Acad Sci U S A
|
2010
|
0.98
|
|
32
|
TMA-Combiner, a simple software tool to permit analysis of replicate cores on tissue microarrays.
|
Mod Pathol
|
2005
|
0.98
|
|
33
|
Indolent T-lymphoblastic proliferation (iT-LBP): a review of clinical and pathologic features and distinction from malignant T-lymphoblastic lymphoma.
|
Adv Anat Pathol
|
2013
|
0.97
|
|
34
|
The inducible T-cell co-stimulator molecule is expressed on subsets of T cells and is a new marker of lymphomas of T follicular helper cell-derivation.
|
Haematologica
|
2010
|
0.96
|
|
35
|
The utility of PAX5 immunohistochemistry in the diagnosis of undifferentiated malignant neoplasms.
|
Mod Pathol
|
2007
|
0.96
|
|
36
|
The transcription factor LMO2 is a robust marker of vascular endothelium and vascular neoplasms and selected other entities.
|
Am J Clin Pathol
|
2009
|
0.94
|
|
37
|
The spectrum of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: a description of 10 cases.
|
Mod Pathol
|
2012
|
0.93
|
|
38
|
Human germinal center-associated lymphoma protein expression is associated with improved failure-free survival in Brazilian patients with classical Hodgkin lymphoma.
|
Leuk Lymphoma
|
2009
|
0.93
|
|
39
|
Transmembrane adaptor molecules: a new category of lymphoid-cell markers.
|
Blood
|
2005
|
0.93
|
|
40
|
Indolent T-lymphoblastic proliferation with disseminated multinodal involvement and partial CD33 expression.
|
Am J Surg Pathol
|
2014
|
0.92
|
|
41
|
Characterization of D-cyclin proteins in hematolymphoid neoplasms: lack of specificity of cyclin-D2 and D3 expression in lymphoma subtypes.
|
Mod Pathol
|
2010
|
0.92
|
|
42
|
Aggressive EBV-associated lymphoproliferative disorder: a prodrome to diffuse large B-cell lymphoma?
|
Appl Immunohistochem Mol Morphol
|
2012
|
0.91
|
|
43
|
Microtubule-associated protein-2 is a sensitive marker of primary and metastatic neuroblastoma.
|
Am J Surg Pathol
|
2009
|
0.91
|
|
44
|
Expression profiles of MYC protein and MYC gene rearrangement in lymphomas.
|
Am J Surg Pathol
|
2015
|
0.91
|
|
45
|
Programmed death 1 expression in variant immunoarchitectural patterns of nodular lymphocyte predominant Hodgkin lymphoma: comparison with CD57 and lymphomas in the differential diagnosis.
|
Hum Pathol
|
2010
|
0.91
|
|
46
|
Identification of LMO2 transcriptome and interactome in diffuse large B-cell lymphoma.
|
Blood
|
2012
|
0.90
|
|
47
|
CD137 is expressed in follicular dendritic cell tumors and in classical Hodgkin and T-cell lymphomas: diagnostic and therapeutic implications.
|
Am J Pathol
|
2012
|
0.90
|
|
48
|
Immunoarchitectural patterns in follicular lymphoma: efficacy of HGAL and LMO2 in the detection of the interfollicular and diffuse components.
|
Am J Surg Pathol
|
2010
|
0.90
|
|
49
|
IgG4-related systemic sclerosing disease of the ocular adnexa: a potential mimic of ocular lymphoma.
|
Am J Clin Pathol
|
2012
|
0.89
|
|
50
|
EBV can protect latently infected B cell lymphomas from death receptor-induced apoptosis.
|
J Immunol
|
2006
|
0.89
|
|
51
|
CD137 ligand is expressed in primary and secondary lymphoid follicles and in B-cell lymphomas: diagnostic and therapeutic implications.
|
Am J Surg Pathol
|
2013
|
0.87
|
|
52
|
Expression of the human germinal-centre-associated lymphoma protein in diffuse large B-cell lymphomas in patients with rheumatoid arthritis.
|
Br J Haematol
|
2008
|
0.87
|
|
53
|
The usefulness of immunohistochemistry in the diagnosis of follicular lymphoma in bone marrow biopsy specimens.
|
Am J Clin Pathol
|
2002
|
0.87
|
|
54
|
LITAF, a BCL6 target gene, regulates autophagy in mature B-cell lymphomas.
|
Br J Haematol
|
2013
|
0.86
|
|
55
|
Low CD27 expression in plasma cell dyscrasias correlates with high-risk disease: an immunohistochemical analysis.
|
Am J Clin Pathol
|
2006
|
0.85
|
|
56
|
Utility of syndecan-1 (CD138) expression in the diagnosis of undifferentiated malignant neoplasms: a tissue microarray study of 1,754 cases.
|
Appl Immunohistochem Mol Morphol
|
2005
|
0.85
|
|
57
|
Immunoarchitectural patterns in nodal marginal zone B-cell lymphoma: a study of 51 cases.
|
Am J Clin Pathol
|
2009
|
0.84
|
|
58
|
Low stage follicular lymphoma: biologic and clinical characterization according to nodal or extranodal primary origin.
|
Am J Surg Pathol
|
2009
|
0.84
|
|
59
|
Intracellular signalling molecules as immunohistochemical markers of normal and neoplastic human leucocytes in routine biopsy samples.
|
Br J Haematol
|
2004
|
0.84
|
|
60
|
Lymphoma cell VEGFR2 expression detected by immunohistochemistry predicts poor overall survival in diffuse large B cell lymphoma treated with immunochemotherapy (R-CHOP).
|
Br J Haematol
|
2009
|
0.83
|
|
61
|
CD81 protein is expressed at high levels in normal germinal center B cells and in subtypes of human lymphomas.
|
Hum Pathol
|
2009
|
0.83
|
|
62
|
Expression of the bcl-6 and MUM1/IRF4 proteins correlate with overall and disease-specific survival in patients with primary cutaneous large B-cell lymphoma: a tissue microarray study.
|
J Cutan Pathol
|
2005
|
0.83
|
|
63
|
Molecular and genomic aberrations in Chlamydophila psittaci negative ocular adnexal marginal zone lymphomas.
|
Am J Hematol
|
2013
|
0.82
|
|
64
|
LMO2 and BCL6 are associated with improved survival in primary central nervous system lymphoma.
|
Br J Haematol
|
2014
|
0.82
|
|
65
|
A novel method for making "tissue" microarrays from small numbers of suspension cells.
|
Appl Immunohistochem Mol Morphol
|
2005
|
0.82
|
|
66
|
PD-1 expression in T-cell lymphomas and reactive lymphoid entities: potential overlap in staining patterns between lymphoma and viral lymphadenitis.
|
Am J Surg Pathol
|
2010
|
0.82
|
|
67
|
Expression pattern of FCRL (FREB, FcRX) in normal and neoplastic human B cells.
|
Br J Haematol
|
2004
|
0.81
|
|
68
|
Expression of LMO2 is associated with t(14;18)/IGH-BCL2 fusion but not BCL6 translocations in diffuse large B-cell lymphoma.
|
Am J Clin Pathol
|
2010
|
0.80
|
|
69
|
Immunostaining to identify molecular subtypes of diffuse large B-cell lymphoma in a population-based epidemiologic study in the pre-rituximab era.
|
Int J Mol Epidemiol Genet
|
2011
|
0.79
|
|
70
|
Kappa and lambda light chain mRNA in situ hybridization compared to flow cytometry and immunohistochemistry in B cell lymphomas.
|
Diagn Pathol
|
2014
|
0.79
|
|
71
|
Cytologic diagnosis of Burkitt lymphoma.
|
Cancer
|
2005
|
0.79
|
|
72
|
Clinicopathological features of aggressive B-cell lymphomas including B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell and Burkitt lymphomas: a study of 44 patients from Argentina.
|
Ann Diagn Pathol
|
2012
|
0.78
|
|
73
|
C-C chemokine receptor 1 expression in human hematolymphoid neoplasia.
|
Am J Clin Pathol
|
2010
|
0.78
|
|
74
|
The efficacy of HGAL and LMO2 in the separation of lymphomas derived from small B cells in nodal and extranodal sites, including the bone marrow.
|
Am J Clin Pathol
|
2011
|
0.78
|
|
75
|
The spectrum of lymphoblastic, nodal and extranodal T-cell lymphomas: characteristic features and diagnostic dilemmas.
|
Hum Pathol
|
2012
|
0.78
|
|
76
|
Follicular lymphoma in young adults: a clinicopathological and molecular study of 200 patients.
|
Mod Pathol
|
2013
|
0.77
|
|
77
|
The contribution of HGAL/GCET2 in immunohistological algorithms: a comparative study in 424 cases of nodal diffuse large B-cell lymphoma.
|
Mod Pathol
|
2012
|
0.77
|
|
78
|
LIM domain only 2 protein expression, LMO2 germline genetic variation, and overall survival in diffuse large B-cell lymphoma in the pre-rituximab era.
|
Leuk Lymphoma
|
2012
|
0.77
|
|
79
|
Mast cell tryptase and microphthalmia transcription factor effectively discriminate cutaneous mast cell disease from myeloid leukemia cutis.
|
J Cutan Pathol
|
2007
|
0.76
|
|
80
|
HGAL protein expression persists in disorders of germinal center dissolution: potential role of HGAL in the germinal center microenvironment.
|
Appl Immunohistochem Mol Morphol
|
2011
|
0.76
|
|
81
|
Chromosome instability in diffuse large B cell lymphomas is suppressed by activation of the noncanonical NF-κB pathway.
|
Int J Cancer
|
2014
|
0.76
|
|
82
|
Expression of the activating receptor, NKp46 (CD335), in human natural killer and T-cell neoplasia.
|
Am J Clin Pathol
|
2013
|
0.76
|
|
83
|
FHIT, EGFR, and MSH2: possible etiopathologic, prognostic, and predictive role in non-small cell lung carcinoma in Egyptian patients.
|
Appl Immunohistochem Mol Morphol
|
2014
|
0.76
|
|
84
|
LMO2 (LIM domain only 2) is expressed in a subset of acute myeloid leukaemia and correlates with normal karyotype.
|
Histopathology
|
2013
|
0.76
|
|
85
|
Lack of utility of CD20 immunohistochemistry in staging bone marrow biopsies for diffuse large B-cell lymphoma.
|
Appl Immunohistochem Mol Morphol
|
2009
|
0.75
|
|
86
|
Selective immunophenotyping for diagnosis of B-cell neoplasms: immunohistochemistry and flow cytometry strategies and results.
|
Appl Immunohistochem Mol Morphol
|
2013
|
0.75
|
|
87
|
Variable expression of B-cell transcription factors in reactive immunoblastic proliferations: a potential mimic of classical Hodgkin lymphoma.
|
Am J Surg Pathol
|
2014
|
0.75
|
|
88
|
Follicular dendritic cell immunohistochemical markers in angioimmunoblastic T-cell lymphoma.
|
Appl Immunohistochem Mol Morphol
|
2005
|
0.75
|
|
89
|
Building "tissue" microarrays from suspension cells.
|
Methods Mol Biol
|
2010
|
0.75
|
|
90
|
Tissue microarrays from bone marrow aspirates for high-throughput assessment of immunohistologic markers in pediatric acute leukemia.
|
Pediatr Dev Pathol
|
2007
|
0.75
|
|
91
|
LMO2 protein expression predicts survival in patients with rheumatoid arthritis and diffuse large B-cell lymphoma.
|
Leuk Lymphoma
|
2011
|
0.75
|
|
92
|
Myeloid Cell Nuclear Differentiation Antigen (MNDA) Expression Distinguishes Extramedullary Presentations of Myeloid Leukemia From Blastic Plasmacytoid Dendritic Cell Neoplasm.
|
Am J Surg Pathol
|
2016
|
0.75
|
|
93
|
Large atypical cells of lymphomatoid papulosis are CD56-negative: a study of 18 cases.
|
J Cutan Pathol
|
2002
|
0.75
|
|
94
|
Usefulness of HGAL and LMO2 immunohistochemistry in the identification of follicular lymphomas of the non-gastric gastrointestinal tract.
|
Appl Immunohistochem Mol Morphol
|
2013
|
0.75
|
|
95
|
CD10 expression in peripheral T-cell lymphomas complicated by a proliferation of large B-cells.
|
Mod Pathol
|
2006
|
0.75
|